Minutes later, Monica Calajan, a black nurse from the city of São Paulo, became the first Brazilian to be vaccinated. Calazans, who is at high risk for Kovid-19 complications and works in an ICU that has a 90% capacity or above since April, exploded in tears before receiving a Coronavac shot.
“You don’t understand what this means for me,” he told São Paulo State Governor João Doria.
Coronavac, developed by the Chinese company Synovac, is now authorized to use 6 million imported supplements. It has a history in the state of São Paulo, where the local Butanan Institute conducted clinical trials of the third phase of the vaccine. Butanon will also produce future supplements.
The technical report of the ANVISA Greenlighting Coronavac stressed that the agency also took into account the urgency and “absence of therapeutic options” of Brazil’s Skywatering Covid-19 cases.
It also recommended that the vaccine be further monitored, with the Butanon Institute not providing critical data from its Phase III study, such as the duration of protection provided by the vaccine and its effect on the elderly, comradeship, and other patients. With groups.
In June, Fiocruz signed an agreement with drug giant AstraZeneca to purchase and produce the vaccine. After a gradual delay, the Brazilian government signed a contract for 256 million doses in October and announced that it would receive the first in December.
After another series of delays, FiroCruz hopes to receive the first shipment by the end of January.
CNN’s Rodrigo Pedroso from Sao Paulo and Katlin Hu from New York reported.